Cargando…
Can fosfomycin be an alternative therapy for infections caused by E. coli harbouring dual resistance: NDM and four-amino acid insertion in PBP3?
NDM-expressing Escherichia coli infections are challenging to treat, due to limited treatment options. E. coli with four-amino acid inserts (YRIN/YRIK) are also common in India and it has been reported to reduce the susceptibility to aztreonam/avibactam and the clinically used triple combination cef...
Autores principales: | Bakthavatchalam, Yamuna Devi, Shankar, Abirami, Manokaran, Yuvasri, Walia, Kamini, Veeraraghavan, Balaji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985326/ https://www.ncbi.nlm.nih.gov/pubmed/36880086 http://dx.doi.org/10.1093/jacamr/dlad016 |
Ejemplares similares
-
Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2020) -
In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations
por: Palwe, Snehal, et al.
Publicado: (2021) -
Loss of exclusivity of ceftazidime/avibactam in low- and middle-income countries: a test for antibiotic stewardship practice
por: Veeraraghavan, Balaji, et al.
Publicado: (2023) -
Insights into the complete genomes of carbapenem-resistant Acinetobacter baumannii harbouring bla
(OXA-23, )
bla
(OXA-420) and bla
(NDM-1) genes using a hybrid-assembly approach
por: Vijayakumar, Saranya, et al.
Publicado: (2020) -
Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India
por: Ragupathi, Naveen Kumar Devanga, et al.
Publicado: (2019)